Accuray reported $61.38M in Cost of Sales for its first fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Cost Of Sales Change
Abbott ABT:US $ 4987M 267M
Accuray ARAY:US $ 61.38M 12.26M
Atricure ATRC:US $ 18.98M 0.78M
Boston Scientific BSX:US $ 967M 16M
Cardiovascular Systems CSII:US $ 14.79M 3.28M
Cryolife CRY:US $ 26.49M 1.53M
Edwards Lifesciences EW:US $ 299.3M 10.2M
Hologic HOLX:US $ 489.1M 4.3M
Inogen INGN:US $ 45.38M 7.56M
Mesa Laboratories MLAB:US $ 23.77M 2.3M
Natus Medical BABY:US $ 54.38M 1.23M
Orthofix International OFIX:US $ 28.32M 4.94M
Surmodics SRDX:US $ 5.11M 0.61M
Tandem Diabetes Care TNDM:US $ 84.81M 11.45M